Enhanced Nucleosome Assembly at CpG Sites Containing an Extended 5-methylcytosine Analogue
Overview
Authors
Affiliations
Methylation of cytosine to 5-methylcytosine (mC) at CpG sites is a prevalent reversible epigenetic mark in vertebrates established by DNA methyltransferases (MTases); the attached methyl groups can alter local structure of DNA and chromatin as well as binding of dedicated proteins. Nucleosome assembly on methylated DNA has been studied extensively, however little is known how the chromatin structure is affected by larger chemical variations in the major groove of DNA. Here, we studied the nucleosome formation in vitro on DNA containing an extended 5mC analog, 5-(6-azidohex-2-ynyl)cytosine (ahyC) installed at biological relevant CpG sites. We found that multiple ahyC residues on 80-Widom and Hsp70 promoter DNA fragments proved compatible with nucleosome assembly. Moreover, unlike mC, ahyC increases the affinity of histones to the DNA, partially altering nucleosome positioning, stability, and the action of chromatin remodelers. Based on molecular dynamics calculations, we suggest that these new features are due to increased DNA flexibility at ahyC-modified sites. Our findings provide new insights into the biophysical behavior of modified DNA and open new ways for directed design of synthetic nucleosomes.
Baryshev M, Maksimova I, Sasoveca I Int J Mol Sci. 2024; 25(19).
PMID: 39409007 PMC: 11476944. DOI: 10.3390/ijms251910678.
An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation.
Feng B, Zheng J, Cai Y, Han Y, Han Y, Wu J Actas Esp Psiquiatr. 2024; 52(3):365-374.
PMID: 38863055 PMC: 11190457. DOI: 10.62641/aep.v52i3.1595.
Hardtke H, Zhang Y Crit Rev Biochem Mol Biol. 2024; 59(1-2):1-19.
PMID: 38288999 PMC: 11209794. DOI: 10.1080/10409238.2024.2306365.
Breindl M, Spitzer D, Gerasimaite R, Kairys V, Schubert T, Henfling R Nucleic Acids Res. 2023; 52(1):337-354.
PMID: 38000389 PMC: 10783490. DOI: 10.1093/nar/gkad1096.
DNA Labeling Using DNA Methyltransferases.
Tomkuviene M, Kriukiene E, Klimasauskas S Adv Exp Med Biol. 2022; 1389:535-562.
PMID: 36350522 DOI: 10.1007/978-3-031-11454-0_19.